儿童急性淋巴细胞白血病细胞遗传学研究的临床意义：柏林-法兰克福-明斯特方案（BFM）试验经验 - Suppr | 超能文献

Clinical significance of cytogenetic studies in childhood acute lymphoblastic leukemia: experience of the BFM trials.

作者信息

Harbott J, Ritterbach J, Ludwig W D, Bartram C R, Reiter A, Lampert F

机构信息

Oncocytogenetic Laboratory, Children's Hospital, University of Giessen, Fed. Rep. of Germany.

出版信息

Recent Results Cancer Res. 1993;131:123-32. doi: 10.1007/978-3-642-84895-7_12.

DOI:10.1007/978-3-642-84895-7_12

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Clinical significance of cytogenetic studies in childhood acute lymphoblastic leukemia: experience of the BFM trials.

Recent Results Cancer Res. 1993;131:123-32. doi: 10.1007/978-3-642-84895-7_12.

2

DNA aneuploidy in childhood acute lymphoblastic leukemia: relation to clinical determinants and prognosis within four consecutive BFM trials.

Recent Results Cancer Res. 1993;131:113-21. doi: 10.1007/978-3-642-84895-7_11.

3

Incidence and prognostic significance of immunophenotypic subgroups in childhood acute lymphoblastic leukemia: experience of the BFM study 86.

Recent Results Cancer Res. 1993;131:269-82. doi: 10.1007/978-3-642-84895-7_24.

4

[Treatment strategy for childhood and adolescent acute lymphoblastic leukemia in first remission].

Rinsho Ketsueki. 2010 Jul;51(7):454-9.

5

Clinical utility of miR-143/miR-182 levels in prognosis and risk stratification specificity of BFM-treated childhood acute lymphoblastic leukemia.

Ann Hematol. 2018 Jul;97(7):1169-1182. doi: 10.1007/s00277-018-3292-y. Epub 2018 Mar 20.

6

Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.

J Clin Oncol. 2008 Jun 20;26(18):3046-50. doi: 10.1200/JCO.2008.16.1117.

7

Long-term treatment results of Polish pediatric and adolescent patients enrolled in the ALL IC-BFM 2002 trial.

Am J Hematol. 2019 Nov;94(11):E307-E310. doi: 10.1002/ajh.25619. Epub 2019 Aug 30.

8

Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.

Haematologica. 2002 Feb;87(2):154-66.

9

Structure and significance of cytogenetic abnormalities in adult patients with Ph-negative acute lymphoblastic leukemia.

Ter Arkh. 2018 Aug 17;90(7):30-37. doi: 10.26442/terarkh201890730-37.

10

The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.

Ann Hematol. 2014 Oct;93(10):1677-84. doi: 10.1007/s00277-014-2106-0. Epub 2014 May 27.

引用本文的文献

1

Ten-year experiences on initial genetic examination in childhood acute lymphoblastic leukaemia in Hungary (1993-2002). Technical approaches and clinical implementation.

Pathol Oncol Res. 2011 Mar;17(1):81-90. doi: 10.1007/s12253-010-9286-2. Epub 2010 Jun 24.

2

Frequency and DNA sequence of tal-1 rearrangement in children with T-cell acute lymphoblastic leukemia.

Ann Hematol. 1992 Jun;64(6):305-8. doi: 10.1007/BF01695477.